Search alternatives:
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
Showing 241 - 260 results of 3,510 for search 'significantly ((((teer decrease) OR (largest decrease))) OR (((nn decrease) OR (mean decrease))))', query time: 0.36s Refine Results
  1. 241
    Effects of CGA on renal biochemical markers.

    Effects of CGA on renal biochemical markers. by Liping Bao (2936715)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 242
    The effects of CGA on renal histopathological injury.

    The effects of CGA on renal histopathological injury. by Liping Bao (2936715)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 243
    Intervention in the CGA-induced activation of the Nrf2 pathway and its inhibition of NLRP3 inflammasome in HK-2 cells.

    Intervention in the CGA-induced activation of the Nrf2 pathway and its inhibition of NLRP3 inflammasome in HK-2 cells. by Liping Bao (2936715)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 244
    Forest Plot of Multivariate Odds Ratios for Risk Factors Associated with Nerve Injury 90 Days After Total Knee Arthroplasty.

    Forest Plot of Multivariate Odds Ratios for Risk Factors Associated with Nerve Injury 90 Days After Total Knee Arthroplasty. by Rahul H. Jayaram (21463899)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 245
    Univariate and Multivariate analysis of risk factors for nerve injury 90-days after TKA.

    Univariate and Multivariate analysis of risk factors for nerve injury 90-days after TKA. by Rahul H. Jayaram (21463899)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 246
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 247
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 248
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 249
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 250
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 251
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 252
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 253
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 254
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 255
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 256
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 257
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 258
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 259
    Spearman’s correlation coefficients between mean scores of each S-Hab-Q factor and the AQ subscales.

    Spearman’s correlation coefficients between mean scores of each S-Hab-Q factor and the AQ subscales. by Vincenza Tarantino (182506)

    Published 2024
    Save to List
    Saved in:
  20. 260
    Variation of the most appropriate p value significance threshold with different ratios of the standard deviations and sample sizes.

    Variation of the most appropriate p value significance threshold with different ratios of the standard deviations and sample sizes. by Farrokh Habibzadeh (12256529)

    Published 2025
    Save to List
    Saved in:

Search Tools: